HomeClinical TopicsFDA approves new drug for psoriasis

FDA approves new drug for psoriasis

On January 21, the U.S. Food and Drug Administration (FDA) approved Cosentyx (secukinumab) to treat adults with moderate-to-severe plaque psoriasis. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content